CD8A and gastric cancer: Our results suggest that the discordant findings encountered in non-neoplastic mucosa and gastric cancer, when comparing the two groups, are determined by an increase of CD8+ and GATA3+ T cells in gastric cancer of non-CVID patients, contrasting with the lack of significant alterations of immune cell counts in CVID patients.